What is the use of migalastat approved by FDA in 2018 August?: (A) Fabry's disease, (B) Breast cancer, (C) Glycogen storage disorder, (D) HIV
Answer is A. migalastat is a pharmacological chaprone that reversibily binds to the active site of alpha galactosidase A protein which is deficient in fabrys disease. Ref:www.pubchem.ncbi.nlm.nih.gov/megalastat.